The Journal of Immunology, Vol 146, Issue 1 194-198, Copyright © 1991 by American Association of Immunologists

ARTICLES

Morphine-induced thymic hypoplasia is glucocorticoid-dependent

Y Sei, K Yoshimoto, T McIntyre, P Skolnick and PK Arora
Laboratory of Neuroscience, NIDDK, National Institutes of Health, Bethesda, MD 20892.

Mice administered morphine as a s.c. pellet implant exhibit a marked and sustained thymic hypoplasia as well as suppression of T lymphocyte functions. In the present study, the effects of morphine on thymocyte differentiation were characterized. Morphine produced a significant decrease in both the number and proportion of CD4+/CD8+ double positive (DP) cells. The percentage of the CD4+/CD8-, CD4-/CD8+, and CD4-/CD8- double negative subsets in these mice was proportionally increased. Morphine also increased the proportion of cells expressing either the epsilon-chain of the CD3 complex or the IL-2R. The initial reduction in the proportion of DP thymocytes appeared fully recovered by 10 days post-implantation, although the number of DP thymocytes gradually returned to normal over a 3-wk period. Morphine administration resulted in a marked increase in serum corticosterone levels, and a single injection of dexamethasone mimicked the effects of morphine on thymus differentiation. Furthermore, adrenalectomy abolished the morphine- induced decrease in CD4+/CD8+ thymocytes relative to a sham-operated group. The present findings are consistent with the hypothesis that morphine-induced thymic hypoplasia may be mediated by an increase in the circulating levels of corticosterone.

This article has been cited by other articles:

				T. Ohara, T. Itoh, and M. Takahashi Immunosuppression by Morphine-Induced Lymphocyte Apoptosis: Is It a Real Issue? Anesth. Analg., October 1, 2005; 101(4): 1117 - 1122. [Abstract] [Full Text] [PDF]

				R. S. Bhat, M. Bhaskaran, A. Mongia, N. Hitosugi, and P. C. Singhal Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation J. Leukoc. Biol., June 1, 2004; 75(6): 1131 - 1138. [Abstract] [Full Text] [PDF]

				H. Friedman, C. Newton, and T. W. Klein Microbial Infections, Immunomodulation, and Drugs of Abuse Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219. [Abstract] [Full Text] [PDF]

				G. Mace, M. Jaume, C. Blanpied, L. Stephan, J. D. Coudert, P. Druet, and G. Dietrich Anti-{micro}-opioid-receptor IgG antibodies are commonly present in serum from healthy blood donors: evidence for a role in apoptotic immune cell death Blood, October 16, 2002; 100(9): 3261 - 3268. [Abstract] [Full Text] [PDF]

				P. Govitrapong, T. Suttitum, N. Kotchabhakdi, and T. Uneklabh Alterations of Immune Functions in Heroin Addicts and Heroin Withdrawal Subjects J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 883 - 889. [Abstract] [Full Text]

				C. Gaveriaux-Ruff, H. W. D. Matthes, J. Peluso, and B. L. Kieffer Abolition of morphine-immunosuppression in mice lacking the µ-opioid receptor gene PNAS, May 26, 1998; 95(11): 6326 - 6330. [Abstract] [Full Text] [PDF]